Neurovascular Diagnostics
PrivateLast Round
Grant
Sep 24, 2024
Total Funding Raised
$4.14M
Company Overview
Neurovascular Diagnostics is a biotechnology company developing a blood-based diagnostic assay for the early detection and risk profiling of unruptured intracranial aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurovascular Diagnostics Comparables
Compare Neurovascular Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MultiplAI Health | 71% | |
| Ischemia Care | 71% | |
| TETmedical, Inc. | 65% | |
Neurovascular Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2024 | ||||
| Grant | Jan 11, 2024 | ||||
| Grant | Nov 6, 2019 | ||||
| Grant | Nov 6, 2019 | ||||
| Grant | Feb 4, 2018 | ||||
Grant | Feb 4, 2018 |
Neurovascular Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
| University at Buffalo Center for Advanced Technology in Big Data and Health Sciences | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2024
Received grant from University at Buffalo Center for Advanced Technology.
- Jan 11, 2024
$3M grant from the National Institutes of Health (NIH)
Neurovascular Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurovascular Diagnostics's valuation, stock price, and market status.